Table 3.
Confirmation of pulmonary artery endothelial cell phenotype from representative samples
Subject No. | Source | CD-31 | vWF | VE-cadherin | AcLDL uptake | α-SMA |
---|---|---|---|---|---|---|
14 | Control | + | + | + | + | − |
18 | Idiopathic PAH, controlled hemodynamics | + | + | + | + | − |
13 | HIV associated PAH, high PVR | + | + | + | + | − |
7 | Portopulmonary hypertension, high CO, low PVR | + | + | + | + | − |
vWF=von Willebrand factor; VE=vascular endothelial; AcLDL=acetylated low density lipoprotein; α-SMA=alpha-smooth muscle cell actin; HPAECs=human pulmonary artery endothelial cells; ND=not done; PAH=pulmonary arterial hypertension; HIV=human immunodeficiency virus; PVR=pulmonary vascular resistance; CO=cardiac output. + indicates that 100% of the cells stained positive for antibody or took up AcLDL; − indicates that all cells were negative for antibody staining.